124 related articles for article (PubMed ID: 9709266)
1. An overview of the breast cancer screening controversy.
Kopans DB
J Natl Cancer Inst Monogr; 1997; (22):1-3. PubMed ID: 9709266
[TBL] [Abstract][Full Text] [Related]
2. Why question screening mammography for women in their forties?
Fletcher SW
Radiol Clin North Am; 1995 Nov; 33(6):1259-71. PubMed ID: 7480669
[TBL] [Abstract][Full Text] [Related]
3. Evidence of efficacy of mammographic screening for women in their forties.
Dupont WD
Cancer; 1994 Aug; 74(4):1204-6. PubMed ID: 8055438
[No Abstract] [Full Text] [Related]
4. Breast cancer screening among women in their forties: an overview of the issues.
Fletcher SW
J Natl Cancer Inst Monogr; 1997; (22):5-9. PubMed ID: 9709267
[TBL] [Abstract][Full Text] [Related]
5. Variation of benefits and harms of breast cancer screening with age.
Harris R
J Natl Cancer Inst Monogr; 1997; (22):139-43. PubMed ID: 9709290
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer screening among women younger than age 50: a current assessment of the issues.
Smith RA
CA Cancer J Clin; 2000; 50(5):312-36. PubMed ID: 11075240
[TBL] [Abstract][Full Text] [Related]
7. Retrospective cost-effectiveness analysis of screening mammography.
Stout NK; Rosenberg MA; Trentham-Dietz A; Smith MA; Robinson SM; Fryback DG
J Natl Cancer Inst; 2006 Jun; 98(11):774-82. PubMed ID: 16757702
[TBL] [Abstract][Full Text] [Related]
8. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
[TBL] [Abstract][Full Text] [Related]
9. The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years.
Frisell J; Lidbrink E
J Natl Cancer Inst Monogr; 1997; (22):49-51. PubMed ID: 9709275
[TBL] [Abstract][Full Text] [Related]
10. [Cancer of the breast: mass screening by mammography is not justified].
Colin C
Rev Med Liege; 1998 Apr; 53(4):212-3. PubMed ID: 9641016
[TBL] [Abstract][Full Text] [Related]
11. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.
J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883
[TBL] [Abstract][Full Text] [Related]
12. NIH Consensus Statement. Breast cancer screening for women ages 40-49.
NIH Consens Statement; 1997 Jan 21-23; 15(1):1-35. PubMed ID: 9267441
[TBL] [Abstract][Full Text] [Related]
13. What are the benefits and costs of screening mammograms on Kentucky women aged 40-49?
Spratt JS; Gaines BM; Aaron WS; Cerrito P
J Surg Oncol; 1996 Oct; 63(2):71-6. PubMed ID: 8888797
[No Abstract] [Full Text] [Related]
14. Performance of a subsidised mammographic screening programme in Malaysia, a middle-income Asian country.
Lee M; Mariapun S; Rajaram N; Teo SH; Yip CH
BMC Public Health; 2017 Jan; 17(1):127. PubMed ID: 28129762
[TBL] [Abstract][Full Text] [Related]
15. Screening fundamentals.
Smith RA
J Natl Cancer Inst Monogr; 1997; (22):15-9. PubMed ID: 9709269
[TBL] [Abstract][Full Text] [Related]
16. Current status of screening mammography.
Feig SA
Obstet Gynecol Clin North Am; 2002 Mar; 29(1):123-36. PubMed ID: 11892862
[TBL] [Abstract][Full Text] [Related]
17. Risk- and cost-benefit analyses of breast screening programs derived from absorbed dose measurements in The Netherlands.
Zuur C; Broerse JJ
Diagn Imaging Clin Med; 1985; 54(3-4):211-22. PubMed ID: 3928229
[TBL] [Abstract][Full Text] [Related]
18. Economic considerations in breast cancer screening of older women.
Brown ML
J Gerontol; 1992 Nov; 47 Spec No():51-8. PubMed ID: 1430883
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effectiveness analysis of breast cancer screening with mammography].
Iinuma T
Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
